NCT03098589 2025-03-30
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Celgene
Completed
Celgene
Deciphera Pharmaceuticals, LLC
Celgene
Celgene
Novartis
Merck Sharp & Dohme LLC
Merck KGaA, Darmstadt, Germany
Astellas Pharma Inc
Newron Pharmaceuticals SPA